Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy in Hormone Receptor-positive (HR+)/HER2 Receptor-negative (HER2-) Metastatic Breast Cancer (MBC): a Real World Multicentre Italian Study
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Fulvestrant (Primary) ; Letrozole (Primary) ; Palbociclib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 27 Aug 2020 New trial record